Novadel Pharma Overview
- Year Founded
-
1982
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Novadel Pharma General Information
Description
Developer of a oral spray formulations of marketed pharmaceutical products. The company develops product that target nausea, migraine headache and disorders of the central nervous system.
Contact Information
Website
www.novadel.comCorporate Office
- 1200 Route 22 East
- Suite 2000
- Bridgewater, NJ 08807
- United States
Corporate Office
- 1200 Route 22 East
- Suite 2000
- Bridgewater, NJ 08807
- United States
Novadel Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 13-Aug-2013 | Completed | Generating Revenue | |||
| 4. Grant | 03-Nov-2010 | Completed | Generating Revenue | |||
| 3. PIPE | 21-Oct-2008 | Completed | Generating Revenue | |||
| 2. PIPE | 29-Dec-2006 | $14.2M | $21.2M | Completed | Generating Revenue | |
| 1. PIPE | 27-May-2005 | $7M | $7M | Completed | Generating Revenue |
Novadel Pharma Patents
Novadel Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150051216-A1 | Oral spray formulations and methods for administration of sildenafil | Active | 05-Dec-2011 | ||
| US-9186321-B2 | Oral spray formulations and methods for administration of sildenafil | Inactive | 05-Dec-2011 | ||
| WO-2013085904-A1 | Oral spray formulations and methods for administration of sildenafil | Inactive | 05-Dec-2011 | ||
| WO-2011156405-A2 | Oral spray formulations and methods for administration of sildenafil | Inactive | 07-Jun-2010 | ||
| WO-2011156405-A3 | Oral spray formulations and methods for administration of sildenafil | Inactive | 07-Jun-2010 | A61K9/006 |
Novadel Pharma Signals
Novadel Pharma Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Heights Capital | Growth/Expansion | Minority | ||
| Henderson Equity Partners | Fund of Funds | Minority | ||
| La Caisse | PE/Buyout | Minority | ||
| ProQuest Investments | Venture Capital | Minority |
Novadel Pharma FAQs
-
When was Novadel Pharma founded?
Novadel Pharma was founded in 1982.
-
Where is Novadel Pharma headquartered?
Novadel Pharma is headquartered in Bridgewater, NJ.
-
What is the size of Novadel Pharma?
Novadel Pharma has 4 total employees.
-
What industry is Novadel Pharma in?
Novadel Pharma’s primary industry is Drug Delivery.
-
Is Novadel Pharma a private or public company?
Novadel Pharma is a Private company.
-
What is Novadel Pharma’s current revenue?
The current revenue for Novadel Pharma is .
-
How much funding has Novadel Pharma raised over time?
Novadel Pharma has raised $25.2M.
-
Who are Novadel Pharma’s investors?
Heights Capital, Henderson Equity Partners, La Caisse, and ProQuest Investments have invested in Novadel Pharma.
-
When was Novadel Pharma acquired?
Novadel Pharma was acquired on 13-Aug-2013.
-
Who acquired Novadel Pharma?
Novadel Pharma was acquired by Arovella Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process